A Randomized Phase 3 Trial Evaluating the Safety and Efficacy of Avacopan in Patients with New or Relapsing Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis-MedSci.cn

A Randomized Phase 3 Trial Evaluating the Safety and Efficacy of Avacopan in Patients with New or Relapsing Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis

Merkel, PA; Jayne, D; Schall, TJ; Bekker, P; Hillson, J

ARTHRITIS & RHEUMATOLOGY, 2018; 70 ():

科室
- - 订阅+
  - 更多科室
工具
服务